Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026 and May 2026.
- Largest single sale: $2.2M (27,594 shares) of Dianthus Therapeutics, Inc. on Mar 24, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | Director | Sep 13, 2023 | May 22, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 8, 2026, Dianthus Therapeutics, Inc.: sold 599 shares for $51K, under a disclosed plan; 599 shares acquired by exercising options. 1 filing: 1
- Mar 31, 2026, Dianthus Therapeutics, Inc.: sold 599 shares for $48K, under a disclosed plan; 599 shares acquired by exercising options. 1 filing: 1
- Mar 24, 2026, Dianthus Therapeutics, Inc.: sold 27,594 shares for $2.2M, under a disclosed plan; 27,594 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.